EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 66 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,174 | -39.1% | 5,779 | -33.7% | 0.00% | – |
| Q2 2023 | $75,803 | +165.8% | 8,713 | -10.2% | 0.00% | – |
| Q1 2023 | $28,515 | -21.8% | 9,699 | -6.9% | 0.00% | – |
| Q4 2022 | $36,449 | -55.0% | 10,414 | +1.1% | 0.00% | – |
| Q3 2022 | $81,000 | -8.0% | 10,297 | -7.7% | 0.00% | – |
| Q2 2022 | $88,000 | -32.3% | 11,155 | +4.3% | 0.00% | – |
| Q1 2022 | $130,000 | -7.1% | 10,691 | -6.3% | 0.00% | – |
| Q4 2021 | $140,000 | +17.6% | 11,408 | 0.0% | 0.00% | – |
| Q3 2021 | $119,000 | -54.6% | 11,408 | -60.9% | 0.00% | – |
| Q2 2021 | $262,000 | – | 29,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $36,461,013 | 27.59% |
| ACUTA CAPITAL PARTNERS, LLC | 382,000 | $3,323,400 | 2.25% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,423,897 | $29,787,904 | 1.59% |
| Cormorant Asset Management, LP | 3,200,000 | $27,840,000 | 1.56% |
| Caligan Partners LP | 310,298 | $2,699,593 | 1.52% |
| Samsara BioCapital, LLC | 432,000 | $3,758,400 | 0.66% |
| RA Capital Management | 3,370,506 | $29,323,402 | 0.55% |
| SECTORAL ASSET MANAGEMENT INC | 311,277 | $2,708,110 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 209,949 | $1,826,556 | 0.26% |
| BARD ASSOCIATES INC | 30,674 | $266,864 | 0.10% |